Bases de datos bibliográficos Pascal y Francis

Ayuda

Resultados de su búsqueda

Su búsqueda

is.\*:("0939-1517")

Tipo de documento [dt]

A-Z Z-A Frecuencia ↓ Frecuencia ↑
Exportación CSV

Año de publicación [py]

A-Z Z-A Frecuencia ↓ Frecuencia ↑
Exportación CSV

Disciplina (documento) [di]

A-Z Z-A Frecuencia ↓ Frecuencia ↑
Exportación CSV

País del autor

A-Z Z-A Frecuencia ↓ Frecuencia ↑
Exportación CSV

Resultados 1 a 25 de 338

  • Página / 14
Exportación

Selección :

  • y

Continuous dopaminergic delivery in Parkinson's diseaseANTONINI, Angelo; URSINO, Giulia; CALANDRELLA, Daniela et al.Journal of neurology. Supplement. 2010, Vol 257, Num 2, issn 0939-1517, S305-S308Conference Paper

The clinical spectrum of levodopa-induced motor complicationsHAMETNER, E; SEPPI, K; POEWE, W et al.Journal of neurology. Supplement. 2010, Vol 257, Num 2, issn 0939-1517, S268-S275Conference Paper

The pathogenesis of Friedreich ataxia and the structure and function of frataxinPANDOLFO, Massimo; PASTORE, Annalisa.Journal of neurology. Supplement. 2009, Vol 256, Num 1, pp 9-17, issn 0939-1517, 9 p.Article

Multicellular models of Friedreich ataxiaPUCCIO, Hélène.Journal of neurology. Supplement. 2009, Vol 256, Num 1, pp 18-24, issn 0939-1517, 7 p.Article

Initiation of Parkinson's disease treatmentREICHMANN, Heinz.Journal of neurology. Supplement. 2008, Vol 255, Num 5, pp 57-59, issn 0939-1517, 3 p.Article

Does inflammation stimulate remyelination?HOHLFELD, Reinhard.Journal of neurology. Supplement. 2007, Vol 254, Num 1, pp 47-54, issn 0939-1517, 8 p.Conference Paper

Autonomic dysfunction in Guillain-Barré syndrome and multiple sclerosisFLACHENECKER, Peter.Journal of neurology. Supplement. 2007, Vol 254, Num 2, pp 96-101, issn 0939-1517, 6 p.Conference Paper

Fatigue in neuroimmunological diseasesGREIM, Brigitte; ENGEL, Claudia; APEL, Annett et al.Journal of neurology. Supplement. 2007, Vol 254, Num 2, pp 102-106, issn 0939-1517, 5 p.Conference Paper

Stress and multiple sclerosisMOHR, David C.Journal of neurology. Supplement. 2007, Vol 254, Num 2, pp 65-68, issn 0939-1517, 4 p.Conference Paper

Sixteenth meeting of the european neurological society, 27-31 May 2006, Lausanne, Switzerland. Symposia and free communicationsJournal of neurology. Supplement. 2006, Vol 253, Num 2, issn 0939-1517, 170 p.Conference Proceedings

Basic principles of intravenous immunoglobulin (IVIg) treatmentSTANGEL, Martin; PUL, Refik.Journal of neurology. Supplement. 2006, Vol 253, Num 5, pp 18-24, issn 0939-1517, 7 p.Conference Paper

IVIG therapy in neurological disorders of childhoodARCHELOS, Juan J; FAZEKAS, Franz.Journal of neurology. Supplement. 2006, Vol 253, Num 5, pp 80-86, issn 0939-1517, 7 p.Conference Paper

Rare indications of IVIG therapy in neurological diseases based on case reports and small studiesTUMANI, Hayrettin.Journal of neurology. Supplement. 2006, Vol 253, Num 5, pp 66-69, issn 0939-1517, 4 p.Conference Paper

Fifteenth Meeting of the European Neurological Society, 18-22 June 2005, Vienna, Austria: abstracts of the symposia and free communicationsJournal of neurology. Supplement. 2005, Vol 252, Num 2, issn 0939-1517, 170 p.Conference Proceedings

History of modern multiple sclerosis therapyLUBLIN, Fred.Journal of neurology. Supplement. 2005, Vol 252, Num 3, pp III3-III9, issn 0939-1517Article

The importance of maintaining effective therapy in multiple sclerosisDURELLI, Luca; CLERICO, Marinella.Journal of neurology. Supplement. 2005, Vol 252, Num 3, pp III38-III43, issn 0939-1517Article

MRI evidence for multiple sclerosis as a diffuse disease of the central nervous systemFILIPPI, Massimo; ROCCA, Maria Assunta.Journal of neurology. Supplement. 2005, Vol 252, Num 5, pp 16-24, issn 0939-1517, 9 p.Conference Paper

Changes observed in multiple sclerosis using magnetic resonance imaging reflect a focal pathology distributed along axonal pathwaysARNOLD, Douglas L.Journal of neurology. Supplement. 2005, Vol 252, Num 5, pp 25-29, issn 0939-1517, 5 p.Conference Paper

Modulating processes within the central nervous system is central to therapeutic control of multiple sclerosisZIEMSSEN, Tjalf.Journal of neurology. Supplement. 2005, Vol 252, Num 5, pp 38-45, issn 0939-1517, 8 p.Conference Paper

Purely systemically active anti-inflammatory treatments are adequate to control multiple sclerosisHARTUNG, Hans-Peter; KIESEIER, Bernd C; HEMMER, Bernhard et al.Journal of neurology. Supplement. 2005, Vol 252, Num 5, pp 30-37, issn 0939-1517, 8 p.Conference Paper

Immunogenicity of recombinant human proteins: causes and consequencesSCHELLEKENS, Huub; CASADEVALL, Nicole.Journal of neurology. Supplement. 2004, Vol 251, Num 2, pp 4-9, issn 0939-1517, 6 p.Article

Fourteenth Meeting of the European Neurological Society, 26-30 June 2004, Barcelona, Spain: Symposia and Free CommunicationsJournal of neurology. Supplement. 2004, Vol 251, Num 3, issn 0939-1517, 206 p.Conference Proceedings

Parkinson's disease- an everlasting challengeREICHMANN, Heinz; JOST, Wolfgang H.Journal of neurology. Supplement. 2004, Vol 251, Num 6, issn 0939-1517, 47 p.Serial Issue

Optimising MS disease-modifying therapies: antibodies in perspectiveGIOVANNONI, Gavin.Journal of neurology. Supplement. 2004, Vol 251, Num 5, pp V.30-V.35, issn 0939-1517Article

Ropinirole: Current status of the studiesJOST, Wolfgang H.Journal of neurology. Supplement. 2004, Vol 251, Num 6, pp VI.13-VI.18, issn 0939-1517Article

  • Página / 14